Startups
Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx.
The 2016 U.S. presidential election was marked by aggressive and often shrill attacks on the biopharma industry over drug pricing.
Fresh off its $7B acquisition, Celgene is planning to open a biopharma incubator on its corporate campus in New Jersey.
Adaptimmune is making strides on becoming a fully integrated cell therapy company behind its T Cell Receptor technology
A look at the latest startups that have emerged in 2018 so far.
It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases.
Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics.
Tango officially launched in 2017 and hit the ground running as a cancer drug target discovery and drug development company based on CRISPR technology.
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California.
Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment.
PRESS RELEASES